Previous Close | 57.73 |
1-Year Change | 0.86% |
6-Months Change | -23.75% |
3-Months Change | -4.45% |
Moving Avg (50d) | 63.643 |
Moving Avg (200d) | 71.808 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 8.51K |
Beta (3-Years) | 1.07 |
Revenue Growth (ttm) | 14.93% |
Net Profit Margin (ttm) | 11.29% |
Return On Assets (ttm) | 5.97% |
EPS (ttm) | 2394379.34 |
PE Ratio (ttm) | - |
Dividend Yield | 0.35% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under... Wikipedia